Detail Information of Post-Translational Modifications
| General Information of Drug Transporter (DT) | |||||
|---|---|---|---|---|---|
| DT ID | DTD0180 Transporter Info | ||||
| Gene Name | SLC25A20 | ||||
| Transporter Name | Carnitine/acylcarnitine translocase | ||||
| Gene ID | |||||
| UniProt ID | |||||
| Post-Translational Modification of This DT | |||||
| Overview ofSLC25A20 Modification Sites with Functional and Structural Information | |||||
| Sequence | MADQPKPISP LKNLLAGGFG GVCLVFVGHP LDTVKVRLQT QPPSLPGQPP MYSGTFDCFR
KTLFREGITG LYRGMAAPII GVTPMFAVCF FGFGLGKKLQ QKHPEDVLSY PQLFAAGMLS GVFTTGIMTP GERIKCLLQI QASSGESKYT GTLDCAKKLY QEFGIRGIYK GTVLTLMRDV PASGMYFMTY EWLKNIFTPE GKRVSELSAP RILVAGGIAG IFNWAVAIPP DVLKSRFQTA PPGKYPNGFR DVLRELIRDE GVTSLYKGFN AVMIRAFPAN AACFLGFEVA MKFLNWATPN L |
||||
| PTM type |
X-Acetylation
X-Methylation
X-Oxidation
X-Phosphorylation
X-Ubiquitination
X: Amino Acid
|
||||
|
Acetylation |
|||||
|---|---|---|---|---|---|
|
Alanine | 1 PTM Phenomena Related to This Residue | Click to Show/Hide the Full List | |||
|
PTM Phenomenon1 |
Have the potential to influence SLC25A20 | [1] | |||
|
Role of PTM |
Potential impacts | ||||
|
Modified Residue |
Alanine |
Modified Location |
2 | ||
|
Experimental Method |
Co-Immunoprecipitation | ||||
|
Detailed Description |
Acetylation at SLC25A20 Alanine 2 has the potential to affect its expression or activity. | ||||
|
Lysine | 4 PTM Phenomena Related to This Residue | Click to Show/Hide the Full List | |||
|
PTM Phenomenon1 |
Inhibiting the activity of SLC25A20 | [2] | |||
|
Role of PTM |
Protein Activity Modulation | ||||
|
Modified Residue |
Lysine |
Modified Location |
148 | ||
|
Experimental Material(s) |
Rat liver mitochondria | ||||
|
Experimental Method |
Co-Immunoprecipitation | ||||
|
Detailed Description |
Acetylation at SLC25A20 lysine 148 have been reported to inhibit its activity. | ||||
|
PTM Phenomenon2 |
Inhibiting the activity of SLC25A20 | [2] | |||
|
Role of PTM |
Protein Activity Modulation | ||||
|
Modified Residue |
Lysine |
Modified Location |
157 | ||
|
Experimental Material(s) |
Rat liver mitochondria | ||||
|
Experimental Method |
Co-Immunoprecipitation | ||||
|
Detailed Description |
Acetylation at SLC25A20 lysine 157 have been reported to inhibit its activity. | ||||
|
PTM Phenomenon3 |
Inhibiting the activity of SLC25A20 | [2] | |||
|
Role of PTM |
Protein Activity Modulation | ||||
|
Modified Residue |
Lysine |
Modified Location |
170 | ||
|
Experimental Material(s) |
Rat liver mitochondria | ||||
|
Experimental Method |
Co-Immunoprecipitation | ||||
|
Detailed Description |
Acetylation at SLC25A20 lysine 170 have been reported to inhibit its activity. | ||||
|
PTM Phenomenon4 |
Inhibiting the activity of SLC25A20 | [2] | |||
|
Role of PTM |
Protein Activity Modulation | ||||
|
Modified Residue |
Lysine |
Modified Location |
244 | ||
|
Experimental Material(s) |
Rat liver mitochondria | ||||
|
Experimental Method |
Co-Immunoprecipitation | ||||
|
Detailed Description |
Acetylation at SLC25A20 lysine 244 have been reported to inhibit its activity. | ||||
|
Methylation |
|||||
|
Arginine | 1 PTM Phenomena Related to This Residue | Click to Show/Hide the Full List | |||
|
PTM Phenomenon1 |
Have the potential to influence SLC25A20 | [3] | |||
|
Role of PTM |
Potential impacts | ||||
|
Modified Residue |
Arginine |
Modified Location |
166 | ||
|
Experimental Method |
Co-Immunoprecipitation | ||||
|
Detailed Description |
Methylation at SLC25A20 Arginine 166 has the potential to affect its expression or activity. | ||||
|
Oxidation |
|||||
|
Cystine | 2 PTM Phenomena Related to This Residue | Click to Show/Hide the Full List | |||
|
PTM Phenomenon1 |
Have the potential to influence SLC25A20 | [4] | |||
|
Role of PTM |
Potential impacts | ||||
|
Modified Residue |
Cystine |
Modified Location |
136 | ||
|
Experimental Method |
Co-Immunoprecipitation | ||||
|
Detailed Description |
Oxidation at SLC25A20 Cystine 136 has the potential to affect its expression or activity. | ||||
|
PTM Phenomenon2 |
Have the potential to influence SLC25A20 | [5] | |||
|
Role of PTM |
Potential impacts | ||||
|
Modified Residue |
Cystine |
Modified Location |
155 | ||
|
Experimental Method |
Co-Immunoprecipitation | ||||
|
Detailed Description |
Oxidation at SLC25A20 Cystine 155 has the potential to affect its expression or activity. | ||||
|
Phosphorylation |
|||||
|
Serine | 7 PTM Phenomena Related to This Residue | Click to Show/Hide the Full List | |||
|
PTM Phenomenon1 |
Have the potential to influence SLC25A20 | [6], [7] | |||
|
Role of PTM |
Potential impacts | ||||
|
Modified Residue |
Serine |
Modified Location |
9 | ||
|
Experimental Method |
Co-Immunoprecipitation | ||||
|
Detailed Description |
Phosphorylation at SLC25A20 Serine 9 has the potential to affect its expression or activity. | ||||
|
PTM Phenomenon2 |
Have the potential to influence SLC25A20 | [8], [9] | |||
|
Role of PTM |
Potential impacts | ||||
|
Modified Residue |
Serine |
Modified Location |
143 | ||
|
Experimental Method |
Co-Immunoprecipitation | ||||
|
Detailed Description |
Phosphorylation at SLC25A20 Serine 143 has the potential to affect its expression or activity. | ||||
|
PTM Phenomenon3 |
Have the potential to influence SLC25A20 | [8], [9] | |||
|
Role of PTM |
Potential impacts | ||||
|
Modified Residue |
Serine |
Modified Location |
144 | ||
|
Experimental Method |
Co-Immunoprecipitation | ||||
|
Detailed Description |
Phosphorylation at SLC25A20 Serine 144 has the potential to affect its expression or activity. | ||||
|
PTM Phenomenon4 |
Have the potential to influence SLC25A20 | [8], [9] | |||
|
Role of PTM |
Potential impacts | ||||
|
Modified Residue |
Serine |
Modified Location |
147 | ||
|
Experimental Method |
Co-Immunoprecipitation | ||||
|
Detailed Description |
Phosphorylation at SLC25A20 Serine 147 has the potential to affect its expression or activity. | ||||
|
PTM Phenomenon5 |
Have the potential to influence SLC25A20 | [9] | |||
|
Role of PTM |
Potential impacts | ||||
|
Modified Residue |
Serine |
Modified Location |
183 | ||
|
Experimental Method |
Co-Immunoprecipitation | ||||
|
Detailed Description |
Phosphorylation at SLC25A20 Serine 183 has the potential to affect its expression or activity. | ||||
|
PTM Phenomenon6 |
Have the potential to influence SLC25A20 | [10], [11] | |||
|
Role of PTM |
Potential impacts | ||||
|
Modified Residue |
Serine |
Modified Location |
205 | ||
|
Experimental Method |
Co-Immunoprecipitation | ||||
|
Detailed Description |
Phosphorylation at SLC25A20 Serine 205 has the potential to affect its expression or activity. | ||||
|
PTM Phenomenon7 |
Have the potential to influence SLC25A20 | [10], [12] | |||
|
Role of PTM |
Potential impacts | ||||
|
Modified Residue |
Serine |
Modified Location |
208 | ||
|
Experimental Method |
Co-Immunoprecipitation | ||||
|
Detailed Description |
Phosphorylation at SLC25A20 Serine 208 has the potential to affect its expression or activity. | ||||
|
Threonine | 2 PTM Phenomena Related to This Residue | Click to Show/Hide the Full List | |||
|
PTM Phenomenon1 |
Have the potential to influence SLC25A20 | [9] | |||
|
Role of PTM |
Potential impacts | ||||
|
Modified Residue |
Threonine |
Modified Location |
189 | ||
|
Experimental Method |
Co-Immunoprecipitation | ||||
|
Detailed Description |
Phosphorylation at SLC25A20 Threonine 189 has the potential to affect its expression or activity. | ||||
|
PTM Phenomenon2 |
Have the potential to influence SLC25A20 | [9] | |||
|
Role of PTM |
Potential impacts | ||||
|
Modified Residue |
Threonine |
Modified Location |
198 | ||
|
Experimental Method |
Co-Immunoprecipitation | ||||
|
Detailed Description |
Phosphorylation at SLC25A20 Threonine 198 has the potential to affect its expression or activity. | ||||
|
Tyrosine | 2 PTM Phenomena Related to This Residue | Click to Show/Hide the Full List | |||
|
PTM Phenomenon1 |
Have the potential to influence SLC25A20 | [9] | |||
|
Role of PTM |
Potential impacts | ||||
|
Modified Residue |
Tyrosine |
Modified Location |
186 | ||
|
Experimental Method |
Co-Immunoprecipitation | ||||
|
Detailed Description |
Phosphorylation at SLC25A20 Tyrosine 186 has the potential to affect its expression or activity. | ||||
|
PTM Phenomenon2 |
Have the potential to influence SLC25A20 | [9] | |||
|
Role of PTM |
Potential impacts | ||||
|
Modified Residue |
Tyrosine |
Modified Location |
190 | ||
|
Experimental Method |
Co-Immunoprecipitation | ||||
|
Detailed Description |
Phosphorylation at SLC25A20 Tyrosine 190 has the potential to affect its expression or activity. | ||||
|
Ubiquitination |
|||||
|
Lysine | 1 PTM Phenomena Related to This Residue | Click to Show/Hide the Full List | |||
|
PTM Phenomenon1 |
Have the potential to influence SLC25A20 | [13], [14] | |||
|
Role of PTM |
Potential impacts | ||||
|
Modified Residue |
Lysine |
Modified Location |
244 | ||
|
Experimental Method |
Co-Immunoprecipitation | ||||
|
Detailed Description |
Ubiquitination at SLC25A20 Lysine 244 has the potential to affect its expression or activity. | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Li and Dr. Fu.